O60 Icotrokinra, a targeted oral peptide that blocks IL-23 receptor activation, in moderate-to-severe ulcerative colitis: week 12 results from ANTHEM-UC
Oral Abstracts | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A38-A39
10.1136/gutjnl-2026-bsg.59